Search

Your search keyword '"Leliveld A"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Leliveld A" Remove constraint Author: "Leliveld A" Topic medicine.disease Remove constraint Topic: medicine.disease
40 results on '"Leliveld A"'

Search Results

1. Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer

2. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort

3. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250](S0302283819307638)(10.1016/j.eururo.2019.09.035)

4. Propofol sedation without endotracheal intubation is safe for endoscopic submucosal dissection in the esophagus and stomach

5. Elective nodal radiotherapy in prostate cancer

6. Robot-assisted Versus Open Radical Cystectomy in Bladder Cancer: An Economic Evaluation Alongside a Multicentre Comparative Effectiveness Study

7. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Bladder Cancer Patients: A Multicentre Comparative Effectiveness Study

8. Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial 'NIMBUS'

9. Inhibition of tyrosine kinase receptor signaling attenuates fibrogenesis in an ex vivo model of human renal fibrosis

10. Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer

11. Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients

12. Novel treatment protocol for ameliorating refractory, chronic pain in patients with autosomal dominant polycystic kidney disease

13. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort

14. Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour

15. Balancing treatment efficacy, toxicity and complication risk in elderly patients with metastatic renal cell carcinoma

16. Precision-cut human kidney slices as a model to elucidate the process of renal fibrosis

17. Potential Receptors for Targeted Imaging of Lymph Node Metastases in Penile Cancer

18. Kidney histopathology in lethal human sepsis

19. Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial

20. DNA and RNA analysis of intratumour heterogeneity in metastatic clear cell renal cell carcinoma

21. 89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma

22. Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial

23. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer

24. Nephrectomy in patients with autosomal dominant polycystic kidney disease, does size matter?

25. Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer

26. The Mdg On Poverty And Hunger: How Reliable Are The Hunger Estimates?

27. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study

28. High risk bladder cancer

29. Treatment and outcome in muscle invasive bladder cancer

30. Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography

31. Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer

32. Effects of change in surgical approach in T3 renal cell carcinoma (RCC) with intracaval thrombus on complications and survival

33. SP011A MULTIDISCIPLINARY STEPWISE PROTOCOL FOR THE TREATMENT OF REFRACTORY CHRONIC PAIN IN ADPKD PATIENTS: INITIAL RESULTS

34. The clinical impact of routine bladder biopsy after BCG treatment of high grade non muscle invasive bladder cancer

35. Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling

36. Management of extracolonic tumours in patients with Lynch syndrome

37. Inside Poverty and Development in Africa

38. The use of conformation-specific ligands and assays to dissect the molecular mechanisms of neurodegenerative diseases

39. 11C-choline PET/CT in selection of patients for salvage cryoablation in recurrent prostate cancer

40. Results of a Dutch cost-effectiveness model of radium-223 in comparison to cabazitaxel, abiraterone, and enzalutamide in patients with metastatic castration resistant prostate cancer previously treated with docetaxel

Catalog

Books, media, physical & digital resources